DAWN vs VRTX: Which Stock is Better?

Side-by-side comparison of Day One Biopharmaceuticals Inc and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

DAWN

Day One Biopharmaceuticals Inc

$12.11

VRTX

Vertex Pharmaceuticals Inc

$442.08

Key Metrics Comparison

MetricDAWNVRTXWinner
Market Cap$1.04B$113.16BVRTX
P/E RatioN/A31.06VRTX
EPS (TTM)$N/A$14.21VRTX
Revenue Growth-0.6%0.1%VRTX
Gross Margin89.4%52.7%DAWN

Analyze DAWN

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is DAWN or VRTX a better investment?

Comparing DAWN and VRTX: Day One Biopharmaceuticals Inc has a market cap of $1.04B while Vertex Pharmaceuticals Inc has $113.16B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between DAWN and VRTX?

DAWN (Day One Biopharmaceuticals Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: DAWN or VRTX?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: DAWN or VRTX?

VRTX has higher revenue growth at 0.1% vs -0.6% for DAWN.

Which company is more profitable: DAWN or VRTX?

Day One Biopharmaceuticals Inc (DAWN) has higher gross margins at 89.4% compared to 52.7% for VRTX.

Which is the larger company: DAWN or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.16B compared to $1.04B for DAWN.

Should I buy DAWN or VRTX in 2026?

Both DAWN and VRTX have investment merit. DAWN trades at $12.11 while VRTX trades at $442.08. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between DAWN and VRTX stock?

Key differences: Market Cap ($1.04B vs $113.16B), P/E Ratio (N/A vs 31.1x), Revenue Growth (-0.6% vs 0.1%), Gross Margin (89.4% vs 52.7%).

Popular Stock Comparisons